trending Market Intelligence /marketintelligence/en/news-insights/trending/_Andhin-Zw7AQm47ZFpG5Q2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Spark Therapeutics raises $380.4M from common stock offering


Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection


Banking Essentials Newsletter - February Edition


Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Spark Therapeutics raises $380.4M from common stock offering

Spark Therapeutics Inc. closed its underwritten public offering of 5,296,053 common shares to raise net proceeds of about $380.4 million.

The offering included the 690,789 shares sold under the full exercise of the underwriters' option to buy additional shares at the public offering price of $76.00 per share, less the underwriting discount.

J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Co. LLC acted as book-running managers for the offering.